Changes in methodology in 2024 and 2025 added Tukey outlier deletion that is used to set cut points for CAHPS measures.

Elevance is a high-quality stock with consistent EPS growth, trading at a significant discount to peers like UnitedHealth.

CAMP4 Therapeutics, a biopharmaceutical firm backed by healthcare giant Kaiser Permanente on Thursday raised $75 million after pricing its U.S. initial public offering (IPO).

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story PBMs seek removal of ‘biased’ FTC chair, ...

The Loudon County School Board voted unanimously on Thursday, October 3 to join what is being called a “mass action” lawsuit ...

The U.S. government on Thursday announced quality ratings for 2025 Medicare health and prescription drug plans, the first ...

Below is a roundup of payer-centric news headlines you may have missed during the month of October 2024. | In this month's ...

Most employers have little idea what the pharmacy benefit managers they hire do with the money they exchange for the ...

Hungarian oil group MOL expects its refineries to be able to process both Russian and non-Russian crude oils by the end of ...

Industry leader UnitedHealth Group sued CMS last week over its 2025 ratings ... down from 80.2% this year. CVS Health ...

The Federal Trade Commission (FTC) recently sued the three largest pharmacy benefit managers (PBMs) – Caremark Rx, Express Scripts (ESI) and OptumRx ...

Ken Fisher and Warren Buffet are top holders of some of these stocks.